NEW YORK (GenomeWeb) – Roche reported on Thursday a 6 percent increase in revenues from its Diagnostics division for the first half of 2016, driven by strong growth of all diagnostics businesses except diabetes care.

In total, the Swiss pharmaceutical and diagnostics company reported CHF 25.02 billion ($25.5 billion) in half-year sales, a 6 percent increase compared to half-year sales of CHF 23.59 billion in 2015. On a constant currency basis, total sales grew 5 percent in the first half of 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Sep
18
Sponsored by
Horizon Discovery

In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls. 

Oct
10

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.